244 related articles for article (PubMed ID: 11576697)
21. Trimethyl chitosan and its applications in drug delivery.
Mourya VK; Inamdar NN
J Mater Sci Mater Med; 2009 May; 20(5):1057-79. PubMed ID: 19112609
[TBL] [Abstract][Full Text] [Related]
22. Chitosan for enhanced intestinal permeability: prospects for derivatives soluble in neutral and basic environments.
Kotzé AF; Luessen HL; de Boer AG; Verhoef JC; Junginger HE
Eur J Pharm Sci; 1999 Jan; 7(2):145-51. PubMed ID: 9845799
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the mucoadhesive properties of N-trimethyl chitosan chloride.
Snyman D; Hamman JH; Kotze AF
Drug Dev Ind Pharm; 2003 Jan; 29(1):61-9. PubMed ID: 12602493
[TBL] [Abstract][Full Text] [Related]
24. Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers.
Huang A; Su Z; Li S; Sun M; Xiao Y; Ping Q; Deng Y
Drug Deliv; 2014 Aug; 21(5):388-96. PubMed ID: 24188463
[TBL] [Abstract][Full Text] [Related]
25. Chitosan and its derivatives in mucosal drug and vaccine delivery.
van der Lubben IM; Verhoef JC; Borchard G; Junginger HE
Eur J Pharm Sci; 2001 Oct; 14(3):201-7. PubMed ID: 11576824
[TBL] [Abstract][Full Text] [Related]
26. Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement.
Schipper NG; Olsson S; Hoogstraate JA; deBoer AG; Vårum KM; Artursson P
Pharm Res; 1997 Jul; 14(7):923-9. PubMed ID: 9244151
[TBL] [Abstract][Full Text] [Related]
27. Effect of chitosan on epithelial permeability and structure.
Dodane V; Amin Khan M; Merwin JR
Int J Pharm; 1999 May; 182(1):21-32. PubMed ID: 10332071
[TBL] [Abstract][Full Text] [Related]
28. N-alkylation of highly quaternized chitosan derivatives affects the paracellular permeation enhancement in bronchial epithelia in vitro.
Benediktsdóttir BE; Gudjónsson T; Baldursson Ó; Másson M
Eur J Pharm Biopharm; 2014 Jan; 86(1):55-63. PubMed ID: 23608635
[TBL] [Abstract][Full Text] [Related]
29. Effect of the degree of quaternisation of N-trimethyl chitosan chloride on absorption enhancement: in vivo evaluation in rat nasal epithelia.
Hamman JH; Stander M; Kotzé AF
Int J Pharm; 2002 Jan; 232(1-2):235-42. PubMed ID: 11790507
[TBL] [Abstract][Full Text] [Related]
30. N-trimethyl chitosan chloride as absorption enhancer in oral peptide drug delivery. Development and characterization of minitablet and granule formulations.
van der Merwe SM; Verhoef JC; Kotzé AF; Junginger HE
Eur J Pharm Biopharm; 2004 Jan; 57(1):85-91. PubMed ID: 14729083
[TBL] [Abstract][Full Text] [Related]
31. Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: a target for drug delivery.
Cano-Cebrián MJ; Zornoza T; Granero L; Polache A
Curr Drug Deliv; 2005 Jan; 2(1):9-22. PubMed ID: 16305404
[TBL] [Abstract][Full Text] [Related]
32. Preparation and ex vivo evaluation of TEC as an absorption enhancer for poorly absorbable compounds in colon specific drug delivery.
Younessi P; Avadi MR; Shamimi K; Sadeghi AM; Moezi L; Nahid E; Bayati K; Dehpour AR; Rafiee-Tehrani M
Acta Pharm; 2004 Dec; 54(4):339-45. PubMed ID: 15634617
[TBL] [Abstract][Full Text] [Related]
33. Effect of the type of base and number of reaction steps on the degree of quaternization and molecular weight of N-trimethyl chitosan chloride.
Hamman JH; Kotzé AF
Drug Dev Ind Pharm; 2001 May; 27(5):373-80. PubMed ID: 11448044
[TBL] [Abstract][Full Text] [Related]
34. Absorption-promoting effects of chitosan in airway and intestinal cell lines: a comparative study.
Vllasaliu D; Casettari L; Fowler R; Exposito-Harris R; Garnett M; Illum L; Stolnik S
Int J Pharm; 2012 Jul; 430(1-2):151-60. PubMed ID: 22525084
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of Enhanced Oral Absorption of a Nano-Drug Delivery System Loaded with Trimethyl Chitosan Derivatives.
Zhao Y; Lin S; Fang R; Shi Y; Wu W; Zhang W; Chen H
Int J Nanomedicine; 2022; 17():3313-3324. PubMed ID: 35937081
[TBL] [Abstract][Full Text] [Related]
36. Intestinal drug absorption enhancers: synergistic effects of combinations.
Enslin GM; Hamman JH; Kotze AF
Drug Dev Ind Pharm; 2008 Dec; 34(12):1343-9. PubMed ID: 18686089
[TBL] [Abstract][Full Text] [Related]
37. Effects of various absorption enhancers on transport of clodronate through Caco-2 cells.
Raiman J; Törmälehto S; Yritys K; Junginger HE; Mönkkönen J
Int J Pharm; 2003 Aug; 261(1-2):129-36. PubMed ID: 12878401
[TBL] [Abstract][Full Text] [Related]
38. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside.
Uchiyama T; Sugiyama T; Quan YS; Kotani A; Okada N; Fujita T; Muranishi S; Yamamoto A
J Pharm Pharmacol; 1999 Nov; 51(11):1241-50. PubMed ID: 10632081
[TBL] [Abstract][Full Text] [Related]
39. Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models.
Sandri G; Bonferoni MC; Rossi S; Ferrari F; Gibin S; Zambito Y; Di Colo G; Caramella C
Eur J Pharm Biopharm; 2007 Jan; 65(1):68-77. PubMed ID: 16962751
[TBL] [Abstract][Full Text] [Related]
40. Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo.
Luessen HL; de Leeuw BJ; Langemeÿer MW; de Boer AB; Verhoef JC; Junginger HE
Pharm Res; 1996 Nov; 13(11):1668-72. PubMed ID: 8956332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
